Zalicus

Zalicus is an American biomedical company headquartered in Cambridge, Massachusetts. The company is finding new ways to cure pain. In 2013, Zalicus dropped Z160, a painkiller that would treat pain from shingles. The stock symbol is ZLCS.

References

• http://www.reuters.com/article/2013/11/11/us-zalicus-study-pain-idUSBRE9AA0KX20131111. N.p., n.d. Web.
• "Pipeline Overview | Zalicus." Pipeline Overview | Zalicus. N.p., n.d. Web. 27 Nov. 2013.